adults have tried GLP-1 agonists, the class of drugs to which semaglutide and tirzepatide belong, highlighting their growing prominence in weight management strategies
The company states that compounded semaglutide medication can be paid for with HSA or FSA cards
This price difference, combined with the promise of personalized dosing (i.e
However, they are sometimes prescribed off-label for weight loss
Eli Lilly maintains that Mochi is peddling the 'personalised line' unfaithfully, instead selling "mass-manufactured, untested, and unapproved one-size fits-all compounded drugs." An Eli Lilly spokesperson told Pharmaceutical Technology : "[The telehealth companies] are deceptively marketing knockoff tirzepatide as safe and effective for 'cosmetic weight loss', improperly practising medicine or influencing medical decisions, and falsely claiming to sell 'personalised' compounded tirzepatide." Mochi Health develops a compounded version of Novo Nordisk's GLP-1RA semaglutide
Headaches are often tied to dehydration, blood sugar changes, or nausea, which can be side effects, that occur when first starting semaglutide injections